Anna Eramo
Chief Medical Officer · LB PHARMACEUTICALS INC
Individual
- 2025
- Sep 10, 2025
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anna Eramo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Deep Track Biotechnology Master Fund, Ltd. - $20.00M in LBRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anna Eramo?
Anna Eramo is a corporate insider, tracked as Chief Medical Officer of LB PHARMACEUTICALS INC (LBRX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Anna Eramo last file a Form 4?
The only primary Form 4 on record is dated 10 September 2025.